201 related articles for article (PubMed ID: 34071277)
1. Calpastatin-Mediated Inhibition of Calpain Ameliorates Skin Scar Formation after Burn Injury.
Seo CH; Cui HS; Kim JB
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071277
[TBL] [Abstract][Full Text] [Related]
2. Altered K
Seo CH; Cui HS; Kim JB
Transl Res; 2021 Oct; 236():133-146. PubMed ID: 33905948
[TBL] [Abstract][Full Text] [Related]
3. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
[No Abstract] [Full Text] [Related]
4. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
5. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
6. Deep dermal fibroblast profibrotic characteristics are enhanced by bone marrow-derived mesenchymal stem cells.
Ding J; Ma Z; Shankowsky HA; Medina A; Tredget EE
Wound Repair Regen; 2013; 21(3):448-55. PubMed ID: 23627585
[TBL] [Abstract][Full Text] [Related]
7. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.
Crawford J; Nygard K; Gan BS; O'Gorman DB
Exp Dermatol; 2015 Feb; 24(2):120-6. PubMed ID: 25421393
[TBL] [Abstract][Full Text] [Related]
8. Normal skin and hypertrophic scar fibroblasts differentially regulate collagen and fibronectin expression as well as mitochondrial membrane potential in response to basic fibroblast growth factor.
Song R; Bian HN; Lai W; Chen HD; Zhao KS
Braz J Med Biol Res; 2011 May; 44(5):402-10. PubMed ID: 21445528
[TBL] [Abstract][Full Text] [Related]
9. Fibroblasts from post-burn hypertrophic scar tissue synthesize less decorin than normal dermal fibroblasts.
Scott PG; Dodd CM; Ghahary A; Shen YJ; Tredget EE
Clin Sci (Lond); 1998 May; 94(5):541-7. PubMed ID: 9682679
[TBL] [Abstract][Full Text] [Related]
10. The Effects of the Transforming Growth Factor-β1 (TGF-β1) Signaling Pathway on Cell Proliferation and Cell Migration are Mediated by Ubiquitin Specific Protease 4 (USP4) in Hypertrophic Scar Tissue and Primary Fibroblast Cultures.
Huang Y; Wang Y; Wang X; Lin L; Wang P; Sun J; Jiang L
Med Sci Monit; 2020 Apr; 26():e920736. PubMed ID: 32308208
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow concentrate-induced mesenchymal stem cell conditioned medium facilitates wound healing and prevents hypertrophic scar formation in a rabbit ear model.
Hu CH; Tseng YW; Chiou CY; Lan KC; Chou CH; Tai CS; Huang HD; Hu CW; Liao KH; Chuang SS; Yang JY; Lee OK
Stem Cell Res Ther; 2019 Aug; 10(1):275. PubMed ID: 31462299
[TBL] [Abstract][Full Text] [Related]
12. Calpain activity is essential in skin wound healing and contributes to scar formation.
Nassar D; Letavernier E; Baud L; Aractingi S; Khosrotehrani K
PLoS One; 2012; 7(5):e37084. PubMed ID: 22615899
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of mRNA for insulin-like growth factor-1 in post-burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts.
Ghahary A; Shen YJ; Nedelec B; Scott PG; Tredget EE
Mol Cell Biochem; 1995 Jul; 148(1):25-32. PubMed ID: 7476930
[TBL] [Abstract][Full Text] [Related]
14. Angiogenin Attenuates Scar Formation in Burn Patients by Reducing Fibroblast Proliferation and Transforming Growth Factor β1 Secretion.
Pan SC; Lee CH; Chen CL; Fang WY; Wu LW
Ann Plast Surg; 2018 Feb; 80(2S Suppl 1):S79-S83. PubMed ID: 29369907
[TBL] [Abstract][Full Text] [Related]
15. Expression and localization of insulin-like growth factor-1 in normal and post-burn hypertrophic scar tissue in human.
Ghahary A; Shen YJ; Wang R; Scott PG; Tredget EE
Mol Cell Biochem; 1998 Jun; 183(1-2):1-9. PubMed ID: 9655173
[TBL] [Abstract][Full Text] [Related]
16. Suppressive effects of human fetal keratinocytes on the proliferation, differentiation and extracellular matrix synthesis of human hypertrophic scar fibroblasts in vitro.
Wang Z; Song Q; Li H
Mol Med Rep; 2017 Oct; 16(4):5377-5385. PubMed ID: 28849177
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of mRNA for transforming growth factor-beta, type I and type III procollagen in human post-burn hypertrophic scar tissues.
Ghahary A; Shen YJ; Scott PG; Gong Y; Tredget EE
J Lab Clin Med; 1993 Oct; 122(4):465-73. PubMed ID: 8228562
[TBL] [Abstract][Full Text] [Related]
18. Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin.
Fumagalli M; Musso T; Vermi W; Scutera S; Daniele R; Alotto D; Cambieri I; Ostorero A; Gentili F; Caposio P; Zucca M; Sozzani S; Stella M; Castagnoli C
Exp Dermatol; 2007 Jul; 16(7):600-10. PubMed ID: 17576240
[TBL] [Abstract][Full Text] [Related]
19. SnoN residue (1-366) attenuates hypertrophic scars through resistance to transforming growth factor-β1-induced degradation.
Sun GF; Li HC; Zhan YP; Zhang XF; Pan LY; Chen YF; Xu K; Feng DX
Lab Invest; 2019 Dec; 99(12):1861-1873. PubMed ID: 31409891
[TBL] [Abstract][Full Text] [Related]
20. siRNA-targeting transforming growth factor-β type I receptor reduces wound scarring and extracellular matrix deposition of scar tissue.
Wang YW; Liou NH; Cherng JH; Chang SJ; Ma KH; Fu E; Liu JC; Dai NT
J Invest Dermatol; 2014 Jul; 134(7):2016-2025. PubMed ID: 24670383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
